✨ Free AI Report
Syneos Health, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Syneos Health, Inc.
Company Research

Syneos Health, Inc.: Business Overview, Financials & Competitive Analysis

Syneos Health, Inc. scores 4/10 on the AskCyborg Cyborg Score (Mixed). Syneos Health faces near-term financial headwinds and valuation challenges despite leading market position in CRO/commercialization services. The stock has declined 44% over the past year and underperformed the S&P 500 by over 51% as of April 2026. Analyst consensus is Hold. The company is not in a good financial.

What is Syneos Health, Inc.'s industry? Syneos Health, Inc. (syneoshealth.com) operates in Drug Discovery Services. AskCyborg classifies Syneos Health, Inc. under Drug Discovery Services in its company registry.

Syneos Health is a biopharmaceutical solutions company that utilizes outsourced clinical drug development and commercialization services, operating through Clinical Solutions and Commercial Solutions segments. The com...

4/ 10Mixed

Cyborg Score thesis

Syneos Health faces near-term financial headwinds and valuation challenges despite leading market position in...

Read the full analyst-debate transcript →
Industry Drug Discovery Services
3 named competitors
2 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Syneos Health, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Syneos Health, Inc.

AskCyborg analysts argue the bull and bear cases for Syneos Health, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Syneos Health, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Syneos Health, Inc. Overview

Pro stress-test →

Syneos Health is a biopharmaceutical solutions company that utilizes outsourced clinical drug development and commercialization services, operating through Clinical Solutions and Commercial Solutions segments. The company serves small, mid-sized, and large companies in the biopharmaceutical and biotechnology sectors across North America, Europe, and Asia-Pacific.

Strategic Profile

Pro stress-test →

The Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, and devices spanning Phase I to IV clinical development, while the Commercial Solutions segment provides commercialization, communications, and consulting services. The company is a leading integrated contract research and commercialization services provider, positioned as a strategic partner in the drug development lifecycle.

Competitive Landscape

Pro stress-test →

Syneos Health competes with integrated contract research and commercialization service providers including Charles River Laboratories, IQVIA, and Parexel. The company differentiates through its dual Clinical and Commercial Solutions platforms, serving the full drug development and launch cycle. However, competitive intensity and pricing pressure from larger, diversified providers present ongoing challenges.

Industry Context

Syneos Health, Inc. operates in Drug Discovery Services.

Key facts

Founded: 2010 · Headquarters: Morrisville, North Carolina · Employees: 26,751 · Revenue: $5.41B · Market cap: $4.46B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Syneos Health, Inc..

  • Stock has severely underperformed broader market, down 44% in 12 months (as of April 2026) versus S&P 500
  • TTM revenue of $5.41B (March 2026) reflects stable market position in clinical outsourcing and commercial solutions
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • January 2026Appointed Simon Bartle as Chief Human Resources Officer
  • 2026Strategic partnership expansion with causaLens and KAI Conversations for AI-driven biopharma services
Get alerted when Syneos Health, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Clinical Research ServicesIntegrated contract research and preclinical/clinical services→IQVIA ServicesClinical research, data analytics, and commercialization services→Parexel ServicesContract research and medical consulting services→

Compare Syneos Health, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Syneos Health, Inc. operates in Drug Discovery Services. See how the rest of the sector scores on the Cyborg framework.

Browse Drug Discovery Services research →
NEW · MCP server

Ask your AI assistant about Syneos Health, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Syneos Health, Inc. and its top competitor on Cyborg Score”
“What did Syneos Health, Inc. do this quarter?”
“Is Syneos Health, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Syneos Health, Inc. do?+
Syneos Health is a biopharmaceutical solutions company that utilizes outsourced clinical drug development and commercialization services, operating through Clinical Solutions and Commercial Solutions segments. The com...
What is Syneos Health, Inc.'s Cyborg Score?+
Syneos Health, Inc. has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Syneos Health, Inc.'s main competitors?+
Named competitors include Clinical Research Services, IQVIA Services, Parexel Services. The full competitive landscape is in the AskCyborg report.
How can I get the full Syneos Health, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Syneos Health, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Syneos Health, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.